Voxar rebrands 3D product at ECR
Scottish software developer Voxar launched at the ECR a newly rebranded upgrade of its flagship 3D software, Voxar 3D. The new release, version 4.1, introduces a task-based user interface and workflow improvements. The company also showcased its new
Scottish software developer Voxar launched at the ECR a newly rebranded upgrade of its flagship 3D software, Voxar 3D. The new release, version 4.1, introduces a task-based user interface and workflow improvements. The company also showcased its new release of Voxar Colonscreen, version 2.2, and announced details of its new concurrent licensing scheme for Europe. Concurrent licenses allow operators to distribute and postprocess images on multiple machines across a hospital's DICOM network.
Contrast-Enhanced Mammography and High-Concentration ICM Dosing: What a New Study Reveals
June 16th 2025New research showed a 96 to 97 percent sensitivity for contrast-enhanced mammography (CEM) with an increased iodine delivery rate facilitating robust contrast enhancement for women with aggressive breast cancer.
FDA Grants Fast Track Designation to Emerging Agent for Brain PET Imaging
June 11th 2025Currently being evaluated in a phase 2b clinical trial, the 18F-RAD101 PET imaging agent garnered the FDA’s fast track designation for distinguishing between recurrent disease and treatment impact for brain metastases derived from solid tumors.
How to Successfully Launch a CCTA Program at Your Hospital or Practice
June 11th 2025Emphasizing increasing recognition of the capability of coronary computed tomography angiography (CCTA) for the evaluation of acute and stable chest pain, this author defuses common misperceptions and reviews key considerations for implementation of a CCTA program.
